COVID-19 Precipitating Status Epilepticus in a Pediatric Patient

Madison Farley1, Jamshed Zuberi2

  • 1School of Medicine, St. George's University, True Blue, Grenada.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can present with neurological symptoms like seizures, not just respiratory issues. This case highlights the importance of considering COVID-19 in patients with unusual presentations.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • The global spread of SARS-CoV-2 necessitates understanding diverse clinical presentations of COVID-19.
  • Accurate diagnosis and treatment require comprehensive data on how COVID-19 manifests across different patient groups.

Observation:

  • An 8-year-old boy presented with status epilepticus, initially afebrile and without respiratory symptoms.
  • The patient subsequently developed respiratory distress and desaturation, requiring intubation.
  • Brain imaging (CT) was normal, but EEG indicated diffuse cerebral dysfunction.

Findings:

  • The patient tested positive for SARS-CoV-2, confirming COVID-19.
  • The case demonstrated an atypical neurological presentation of COVID-19.
  • Electroencephalogram (EEG) results were abnormal, suggesting widespread brain dysfunction.

Implications:

  • Clinicians should consider COVID-19 in patients presenting with neurological symptoms, even without typical respiratory signs or fever.
  • This case underscores the variability of COVID-19 presentations, particularly in pediatric populations.
  • Awareness of rare neurological manifestations is crucial for timely diagnosis and effective management of COVID-19.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
499
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131